Ledger.Open graph →
SEC Form D · filed July 14, 2016

Tarsa Therapeutics, Inc

Offering
$1.3M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Eric Bednarski · Waltham, MADirectorGregory Lumpkin · Philadelphia, PAExecMartin Edwards · Philadelphia, PADirectorRichard Kollender · Philadelphia, PADirectorJames Tananbaum · Philadelphia, PADirectorDavid Brand · Philadelphia, PAExec · DirectorTony Matzouranis · Laval, Quebec, CanadaDirectorClarissa L. Desjardins · Laval, Quebec, CanadaExec · DirectorYoussef L. Bennani · Laval, Quebec, CanadaExecFrancesco Bellini · Laval, Quebec, CanadaDirectorJoseph L. Rus · Laval, Quebec, CanadaDirectorLewis Geffen · Boston, MAExecDerek Ferguson · Los Angeles, CADirectorAlan J. Cohn · Alexandria, VADirectorMichael Simcha · Holmdel, NJExecTheodore M. Trachtenberg · Holmdel, NJDirectorRishona M. Sender · Holmdel, NJDirectorBenjamin Ungar · Holmdel, NJExec · DirectorLewis Geffen · BOSTON, MAExecJames Tananbaum · Fort Washington, PADirectorDerek Ferguson · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗